Abstract
Hepatocellular carcinoma (HCC) is a frequent type of primary liver cancer, and its prevalence is increasing worldwide. Indeed, the underlying molecular mechanism is not well understood. Previous studies have shown evidence that tight junction (TJ) components were correlated with carcinogenesis and tumor development. Our aims were to determine the serum levels of tight junction protein Zonula Occludens (ZO)-1 and an inflammatory marker such as high-sensitive C-reactive protein (hs-CRP) in HCC patients compared to healthy volunteers and also to identify the association between ZO-1 and inflammation in HCC. Thirty HCC patients and 30 healthy volunteers were recruited in the current study. Clinical data regarding child class, BCLC staging, the number of lesions, tumor size, absence or presence of metastasis, cirrhosis and hepatitis infection were also collected in HCC patients. Plasma ZO-1 and serum hsCRP were analyzed by EIA and ELISA respectively and biochemical parameters by autoanalyser (AU680 Beckman Coulter, USA). Furthermore, hepatic ZO-1 protein expression and tissue localization were examined. Compared to healthy individuals, the serum levels of bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), g...Continue Reading
References
Feb 15, 1982·Cancer·K OhnishiK Okuda
Dec 10, 1998·The American Journal of Pathology·K B HooverP J Bryant
Mar 17, 1999·The Journal of Clinical Investigation·A S Fanning, J M Anderson
Dec 22, 1999·The Journal of Cell Biology·M ItohS Tsukita
Sep 25, 2003·Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan·Norimasa SawadaHideki Chiba
Feb 6, 2004·Gastroenterology·Hashem B El-SeragJames E Everhart
Feb 10, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Thomas Y MaHamid M Said
Oct 28, 2004·Gastroenterology·Mimi C Yu, Jian-Min Yuan
Nov 3, 2004·Gastroenterology·Jessica A DavilaHashem B El-Serag
Oct 20, 2006·Seminars in Liver Disease·H C SpangenbergH E Blum
Apr 4, 2008·Pathology Oncology Research : POR·Erika OrbánAndrás Kiss
Oct 27, 2009·Gastroenterology·Anna S LokUNKNOWN HALT-C Trial Group
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Jan 5, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Takeki UeharaIvan Rusyn
Mar 26, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Neta BarashiAmnon Peled
May 31, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SchlesingerU Nöthlings
Jun 27, 2013·World Journal of Gastroenterology : WJG·Zhong-Yang ShenWei-Ping Zheng
May 14, 2014·Advances in Experimental Medicine and Biology·Anupam Bishayee
Jul 30, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Naoto FujiwaraKazuhiko Koike
Sep 6, 2014·Annals of Surgical Oncology·Akiyoshi KinoshitaMasato Matsushima
Sep 11, 2014·Journal of Cellular Physiology·Chia-Huei LeeKo-Jiunn Liu
Mar 31, 2015·Journal of Pathology and Translational Medicine·Jin Ho ShinEunsil Yu
Jan 17, 2016·Cancer Epidemiology·Magdalena StepienMazda Jenab
Mar 5, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Shuying TianHongyu Jiang
Jun 30, 2016·Nature Reviews. Molecular Cell Biology·Ceniz ZihniMaria S Balda
Oct 18, 2016·Digestive Diseases·Tomoyuki NagaiMasatoshi Kudo
Oct 27, 2016·Liver Cancer·Hiroyuki NakanishiNamiki Izumi
Dec 9, 2016·Cell Death & Disease·Chiara Fazio, Luigi Ricciardiello
Dec 14, 2016·Cancer Cell·Yenkel Grinberg-Bleyer, Sankar Ghosh
Jul 12, 2017·Journal of Carcinogenesis·Yezaz Ahmed GhouriJulie H Rowe